| CEST | Chemical exchange saturation transfer |
| ACOX1 | Acyl–coA oxidase-1 |
| AP | Activating protein |
| APE1/Ref-1 | AP (apurinic/apyrimidinic) endonuclease1/redox effector factor 1 |
| ARG2 | Arginase II |
| ATDC | Ataxia-telangiectasia group D complementing gene |
| CA | Carbonic anhydrase |
| CAF | Cancer associated fibroblast |
| CD | Cluster of differentiation |
| COX-2 | Cyclooxygenase-2 |
| CT | Computed tomography |
| CTLA4 | Cytotoxic T-lymphocyte antigen 4 |
| CTPS1 | Cytidine 5’-triphosphate synthetase |
| DAMP | Damage-associated molecular pattern |
| DFS | Disease free survival |
| DNMT3a | DNA methyltransferase 3a |
| DVL-2 | Dishevelled 2 |
| EGFR | Epidermal growth factor Receptor |
| EMT | Epithelial–mesenchymal transition |
| EpCAM | Epithelial cell adhesion molecule |
| ERK | Extracellular signal-regulated kinase |
| FZD1 | Frizzled-1 |
| GEMM | Genetically engineered mouse model |
| GLI1 | Glioma-associated oncogene homolog 1 (zinc finger protein) |
| GLUT | Glucose transporter |
| GTEx | Genotype-tissue expression |
| Her-2 | Human epidermal growth factor receptor 2 |
| HH | Hedgehog |
| HIF | Hypoxia-inducible factor |
| HK2 | Hexokinase 2 |
| HRE | Hypoxia-responsive element |
| IGF2BP3 | Insulin-like growth factor 2 mRNA-binding protein 3 |
| IL | Interleukin |
| IPMN | Intraductal papillary mucinous neoplasm |
| IQGAP1 | IQ motif containing GTPase activating protein 1 |
| K-ras | Kirsten rat sarcoma viral oncogene homolog |
| KIF14 | Kinesin family member |
| LDHA | Lactate dehydrogenase A |
| MAPK | Mitogen-activated protein kinase |
| MCN | Mucinous cystic neoplasm |
| MCT | Monocarboxylate transporters |
| MEK | Mitogen-activated protein kinase |
| MRI | Magnetic resonance imaging |
| mTOR | Mammalian target of rapamycin |
| MUC | Mucin |
| MVD | Microvessel density |
| MVI | Microvessel integrity |
| NBCe1 | Electrogenic sodium/bicarbonate cotransporter 1 |
| NBCn1 | Electroneutral sodium/bicarbonate cotransporter 1 |
| NF-κB | Nuclear factor κappa-light-chain-enhancer of activated B cells |
| NHE1 | Sodium/hydrogen exchanger 1 |
| OS | Overall survival |
| PanIN | Pancreatic intraepithelial neoplasia |
| PD1 | Programmed cell death protein 1 |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| PDL-1 | Programmed death-ligand 1 |
| PDX | Patient-derived xenograft |
| PET | Positron emission tomography |
| PFS | Progression-free survival |
| PG | Proteoglycan-like domain |
| PGE2 | Prostaglandin E2 |
| pHLIP peptide | pH (low) insertion peptide |
| PI3K | Phosphatidyl inositol 3-kinase |
| PKM2 | Pyruvate kinase muscle isozyme |
| PPBP | Pro-platelet basic protein |
| PSCA | Prostate stem cell antigen |
| qRT-PCR | Real-time quantitative reverse transcription PCR |
| RTK | Receptor tyrosine kinase |
| SERPINB5 | Serpin family B member 5 |
| SHH | Sonic Hedgehog |
| SLC | Solute carrier family membrane transport protein |
| SMO | Smoothened |
| SP1 | Specificity protein 1 |
| TCGA | The cancer genome atlas |
| TET | Ten-eleven translocation enzymes |
| TF | Transcription factors |
| TGF-β | Transforming growth factor β |
| Th cells | T-helper cells |
| TIC | Tumor initiating cell |
| TKT | Transketolase |
| TLR | Toll-like receptor |
| TME | Tumor microenvironment |
| TMPRSS3 | Transmembrane serine protease 3 |
| TNF-α | Tumor necrosis factor α |
| TPM2 | β-tropomyosin |
| Tregs | T regulatory cells |
| TSS | Transcription start site |
| uPAR | Urokinase-type plasminogen activator receptor |
| VEGF | Vascular endothelial growth factor |
| α-SMA | α-smooth muscle actin |